The preventive effect for new vertebral fractures of zoledronic acid and denosumab combined with vitamin D in patients with rheumatoid arthritis.
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis Osteoporosis
- Registration Number
- JPRN-UMIN000030828
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patients with contraindication to denosumab and bisphosphonate 2) The patients who used zoledronic acid or denosumab previously 3) The patients who used teriparatide previously 4) The patients who are not included other intervention study 7) Those who are not approved to be eligible to this study by corresponding researcher
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the incidence ratio of new vertebral fractures after two years
- Secondary Outcome Measures
Name Time Method